0.3066
price up icon1.73%   0.0052
after-market アフターアワーズ: .31 0.0034 +1.11%
loading
前日終値:
$0.3014
開ける:
$0.3255
24時間の取引高:
128.11K
Relative Volume:
0.47
時価総額:
$25.05M
収益:
$1.22M
当期純損益:
$-14.15M
株価収益率:
-1.1792
EPS:
-0.26
ネットキャッシュフロー:
$-6.55M
1週間 パフォーマンス:
-2.48%
1か月 パフォーマンス:
+5.36%
6か月 パフォーマンス:
-16.93%
1年 パフォーマンス:
-29.16%
1日の値動き範囲:
Value
$0.302
$0.3261
1週間の範囲:
Value
$0.298
$0.329
52週間の値動き範囲:
Value
$0.2525
$0.55

IGC Pharma Inc Stock (IGC) Company Profile

Name
名前
IGC Pharma Inc
Name
セクター
Healthcare (1170)
Name
電話
301-983-0998
Name
住所
4336 Montgomery Avenue, Bethesda, MD
Name
職員
16
Name
Twitter
@IGCIR
Name
次回の収益日
2025-02-18
Name
最新のSEC提出書
Name
IGC's Discussions on Twitter

IGC を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IGC
IGC Pharma Inc
0.3066 25.05M 1.22M -14.15M -6.55M -0.26
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

IGC Pharma Inc (IGC) 最新ニュース

pulisher
Jun 02, 2025

BARDA’s $375M to Shionogi for COVID-19 tops early list of 2025 grants - BioWorld MedTech

Jun 02, 2025
pulisher
May 30, 2025

Plus Therapeutics (PSTV) Reports Q1 Loss, Misses Revenue Estimates - sharewise

May 30, 2025
pulisher
May 22, 2025

IGC Pharma Launches Clinical Trial Site in Puerto Rico | IGC Sto - GuruFocus

May 22, 2025
pulisher
May 22, 2025

IGC Pharma Launches Clinical Trial Site in Puerto Rico | IGC Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

IGC Pharma's Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer's Market | IGC Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

IGC Pharma's Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer's Market - ACCESS Newswire

May 22, 2025
pulisher
May 22, 2025

IGC Pharma Targets Puerto Rico's 12.5% Alzheimer's Rate in Strategic Trial Expansion - Stock Titan

May 22, 2025
pulisher
May 13, 2025

IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC - GuruFocus

May 13, 2025
pulisher
May 12, 2025

IGCPharma (IGC) Confirms Genetic Safety of Alzheimer's Drug Ingr - GuruFocus

May 12, 2025
pulisher
May 12, 2025

IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC-AD1, at the 2025 Genetic Toxicology Association Meeting - ACCESS Newswire

May 12, 2025
pulisher
May 04, 2025

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline - Seeking Alpha

May 04, 2025
pulisher
Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 26, 2025

IGC Pharma Announces Equity Analyst Update by Alliance Global Partners (AGP) about the "Progressing Alzheimer-targeting efforts with notable Phase 2 CALMA interim results" - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 26, 2025

IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer's Agitation "CALMA" and Expands Recruitment Strategy - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 25, 2025

Is IGC Pharma Inc (IGC) a good investment opportunity? - uspostnews.com

Apr 25, 2025
pulisher
Apr 25, 2025

IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025 - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 24, 2025

IGC Pharma Welcomes Strategic Investment from Advisors - PharmiWeb.com

Apr 24, 2025
pulisher
Apr 24, 2025

IGC Pharma (IGC) Secures $475K Investment to Advance Alzheimer's Trial | IGC Stock News - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

IGC Pharma Welcomes Strategic Investment from Advisors | IGC Sto - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

IGC Pharma Welcomes Strategic Investment From Advisors - Barchart.com

Apr 24, 2025
pulisher
Apr 23, 2025

The 7 Best Stocks Under 50 Cents To Buy For May 2025! - The Stock Dork

Apr 23, 2025
pulisher
Apr 21, 2025

IGC Pharma Welcomes Industry Leaders to Advisory Board, Supporti - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

IGC Pharma Welcomes Industry Leaders to Advisory Board, Supporting Alzheimer's Innovation and AI-Driven Programs | IGC Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Former MassBio CEO Joins IGC Pharma's Advisory Board to Advance AI-Powered Alzheimer's Programs - Stock Titan

Apr 21, 2025
pulisher
Apr 18, 2025

India Globalization Capital : IGC Announces Results of its 2020 Annual Stockholders Meeting - marketscreener.com

Apr 18, 2025
pulisher
Apr 16, 2025

IGC Pharma, Inc. (IGC) Reports Q3 Loss, Tops Revenue Estimates - MSN

Apr 16, 2025
pulisher
Apr 09, 2025

IGC Pharma expands CALMA trial with addition of Butler Hospital Program - Yahoo Finance

Apr 09, 2025
pulisher
Apr 08, 2025

IGC Pharma Expands Phase 2 Alzheimer's Trial Site - marketscreener.com

Apr 08, 2025
pulisher
Apr 08, 2025

IGC Pharma Expands CALMA Alzheimer's Phase 2 Trial with Prestigious Research Site at Butler Hospital's Memory and Aging Program - Newswire.com

Apr 08, 2025
pulisher
Apr 02, 2025

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Miami Jewish Health - BioSpace

Apr 02, 2025
pulisher
Apr 01, 2025

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addi - GuruFocus

Apr 01, 2025
pulisher
Apr 01, 2025

IGC Pharma announces CALMA Phase 2 trial expansion with Miami Jewish Health - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

IGC Pharma expands CALMA clinical trial - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

IGC Pharma Accelerates Alzheimer's Breakthrough: Key Research Center Joins Phase 2 Trial - Stock Titan

Apr 01, 2025
pulisher
Mar 27, 2025

IGC Pharma posts promising interim data for Alzheimer’s therapy - MSN

Mar 27, 2025
pulisher
Mar 27, 2025

IGC Pharma's Phase 2 Clinical Trial Interim Data Demonstrates Significant Reduction in Sleep Disturbances - BioSpace

Mar 27, 2025
pulisher
Mar 26, 2025

Breakthrough: New Alzheimer's Drug Cuts Sleep Disturbances by 78% in Phase 2 Trial - Stock Titan

Mar 26, 2025
pulisher
Mar 21, 2025

IGC adds new clinical site in Canada for Alzheimer’s agitation therapy trial - Clinical Trials Arena

Mar 21, 2025
pulisher
Mar 20, 2025

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Canadian Hamilton Health Sciences - BioSpace

Mar 20, 2025
pulisher
Mar 20, 2025

IGC Pharma Adds Canadian Site to Phase 2 Trial of Investigational Alzheimer's Dementia Therapy - MarketScreener

Mar 20, 2025
pulisher
Mar 17, 2025

IGC Pharma Expands CALMA Trial with Addition of BayCare Health System in Florida - ACCESS Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

IGC Pharma's Alzheimer's Drug Shows Promise: CALMA Trial Adds New Florida Site - StockTitan

Mar 17, 2025

IGC Pharma Inc (IGC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
大文字化:     |  ボリューム (24 時間):